Tuhura Biosciences, Inc/nv Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
James A. Bianco, M.D., CEO of TuHURA Biosciences, Inc., has filed an amendment to reduce his beneficial ownership below 5% due to share dilution from a fee arrangement, marking an exit filing.